Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

In the latest session, Humana Inc (NYSE: HUM) closed at $220.41 down -1.40% from its previous closing price of $223.55. In other words, the price has decreased by -$1.40 from its previous closing price. On the day, 4.32 million shares were traded. HUM stock price reached its highest trading level at $224.172 during the session, while it also had its lowest trading level at $206.87.

Ratios:

For a deeper understanding of Humana Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.72.

On November 06, 2024, BofA Securities Upgraded its rating to Neutral which previously was Underperform and also upped its target price recommendation from $247 to $308.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 14 ’25 when Rechtin James A. bought 6,530 shares for $229.25 per share. The transaction valued at 1,496,984 led to the insider holds 30,474 shares of the business.

Diamond Susan M bought 10,959 shares of HUM for $2,732,134 on Apr 08 ’25. On Feb 24 ’25, another insider, Huval Timothy S., who serves as the Former Chief Administrative Of of the company, bought 1,247 shares for $258.58 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 26601945088 and an Enterprise Value of 21171140608. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.58, and their Forward P/E ratio for the next fiscal year is 15.93. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.61. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.22 while its Price-to-Book (P/B) ratio in mrq is 1.50. Its current Enterprise Value per Revenue stands at 0.176 whereas that against EBITDA is 5.167.

Stock Price History:

The Beta on a monthly basis for HUM is 0.44, which has changed by -0.42744702 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, HUM has reached a high of $406.46, while it has fallen to a 52-week low of $212.45. The 50-Day Moving Average of the stock is -6.61%, while the 200-Day Moving Average is calculated to be -15.55%.

Shares Statistics:

For the past three months, HUM has traded an average of 1.70M shares per day and 1520680 over the past ten days. A total of 120.69M shares are outstanding, with a floating share count of 120.42M. Insiders hold about 0.22% of the company’s shares, while institutions hold 95.44% stake in the company. Shares short for HUM as of 1749772800 were 4254684 with a Short Ratio of 2.54, compared to 1747267200 on 3440131. Therefore, it implies a Short% of Shares Outstanding of 4254684 and a Short% of Float of 3.95.

Dividends & Splits

According to the company, the forward annual dividend rate for HUM is 3.54, from 3.54 in the trailing year. Against a Trailing Annual Dividend Yield of 0.015835384The stock’s 5-year Average Dividend Yield is 0.8. The current Payout Ratio is 35.45% for HUM, which recently paid a dividend on 2025-06-27 with an ex-dividend date of 2025-06-27. Stock splits for the company last occurred on 1991-08-01 when the company split stock in a 3:2 ratio.